Skip to main content
. 2023 Mar 14;28(6):494–500. doi: 10.1093/oncolo/oyad028

Table 1.

Patients’ characteristics (N = 151).

Characteristics N ()/M (min-max)
Gender [N ()]
 Male 118 (78.1)
Female 33 (21.9)
Age [M (min-max)] 64 (38-87)
Marital status [N ()]
 Single 15 (9.9)
 Married 120 (79.5)
 Divorced 11 (7.3)
 Widowed 5 (3.3)
Education [N ()]
 No formal education 10 (6.6)
 Elementary school 6 (3.9)
 High school 31 (20.5)
 College degree 85 (56.3)
 Beyond college 19 (12.6)
Race [N ()]
 White 98 (64.9)
 Hispanic 29 (19.2)
 Mulato 5 (3.3)
 Southeast Asian 5 (3.3)
 Chinese 4 (2.6)
 Black 3 (2.0)
 Japanese 3 (2.0)
 East Asian 3 (2.0)
 Native Hawaiian 1 (0.7)
Employment status [N ()]
 Retired 81 (53.6)
 More than 32 hours 41 (27.2)
 Disability 13 (8.6)
 Less than 32 hours 9 (6.0)
 Employed (on medical leave) 3 (2.0)
 Other 4 (2.6)
Treatment [N ()]
 Immunotherapy 58 (38.4)
 Targeted therapy 45 (29.8)
 Immuno-TKI combination 21 (13.9)
 No treatment 27 (17.9)